ALPS ADVISORS INC - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 112 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2020. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.

Quarter-by-quarter ownership
ALPS ADVISORS INC ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q1 2024$964,801
+4.1%
95,242
+3.4%
0.01%0.0%
Q4 2023$926,707
-0.2%
92,118
-7.1%
0.01%
-12.5%
Q3 2023$928,745
-61.6%
99,119
+0.7%
0.01%
-61.9%
Q2 2023$2,415,665
+18.0%
98,478
+11.9%
0.02%
+16.7%
Q1 2023$2,047,132
-10.3%
87,973
-2.5%
0.02%
-10.0%
Q4 2022$2,283,266
+63.6%
90,212
+24.6%
0.02%
+53.8%
Q3 2022$1,396,000
-41.4%
72,418
-22.6%
0.01%
-43.5%
Q2 2022$2,383,000
+511.0%
93,544
+516.6%
0.02%
+475.0%
Q1 2022$390,000
-94.4%
15,170
-90.5%
0.00%
-94.0%
Q3 2021$6,967,000
-13.7%
160,089
-6.3%
0.07%
-5.6%
Q2 2021$8,074,000
-23.7%
170,779
-17.3%
0.07%
-31.1%
Q1 2021$10,583,000
+72.1%
206,416
-10.1%
0.10%
+49.3%
Q4 2020$6,150,000
+10.6%
229,652
+41.7%
0.07%
-15.9%
Q3 2020$5,562,000
-15.6%
162,029
+0.7%
0.08%
-6.8%
Q2 2020$6,589,000160,8270.09%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q2 2020
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$39,700,00030.52%
SB INVESTMENT ADVISERS (UK) LTD 22,216,644$565,858,0004.50%
Zebra Capital Management LLC 25,419$647,0001.90%
Alaska Permanent Fund Corp 2,300,000$58,581,0000.84%
CLARK ESTATES INC/NY 180,000$4,585,0000.79%
Temasek Holdings (Private) Ltd 5,602,553$142,697,0250.78%
SECTOR GAMMA AS 110,223$2,807,0000.63%
Avidity Partners Management LP 758,211$19,312,0000.44%
New Vernon Capital Holdings II LLC 14,501$369,0000.30%
DUALITY ADVISERS, LP 116,415$2,965,0000.29%
View complete list of VIR BIOTECHNOLOGY INC shareholders